| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Martin J Colombatto is Director at VTAK. Martin J Colombatto's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider.
Martin J Colombatto has 11 Form 4 filings on record from October 2018 to March 2026, across 2 companies: Director at Flyte Aviation (VJET), 2026; Director at Catheter Precision (VTAK), 2018–2025.
The 12 reported transactions were 5 option or other derivative awards, 5 stock awards, 1 open-market sale and 1 open-market purchase.
Counted by filing, the open-market trades come to 1 purchase worth about $50K and 1 sale worth about $1.
The only open-market purchase was 8,700 shares of VTAK at an average $5.78 on November 19, 2020, about $50K.
The only open-market sale was 3 shares of VTAK at an average $0.40 on January 29, 2025, about $1. Twelve months later VTAK was down 74%.